{"id":1191,"date":"2019-06-25T19:20:49","date_gmt":"2019-06-25T11:20:49","guid":{"rendered":"http:\/\/www.bioactivescreeninglibrary.com\/?p=1191"},"modified":"2022-01-07T10:53:49","modified_gmt":"2022-01-07T02:53:49","slug":"phosphorylation-promotes-autophosphorylation-irak1-dissociates-receptor-complex","status":"publish","type":"post","link":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/2019\/06\/25\/phosphorylation-promotes-autophosphorylation-irak1-dissociates-receptor-complex\/","title":{"rendered":"This phosphorylation promotes the autophosphorylation of IRAK1 which then dissociates from the receptor complex"},"content":{"rendered":"<p>We found relevant this time interval because unpublished data from our laboratory showed that the peak of Hmox-1 expression occurs around 6 hours after reperfusion, providing a reasonable evidence that this time point should be the best to compare changes between the groups shown in our manuscript. As we focused on the transcriptome analysis, we believe that the chosen time point may provide us essential information upon the molecular changes on gene expression that will later interfere in the renal function outcome, as observed by our group and others. Also, this temporal gene expression <a href=\"http:\/\/www.abmole.com\/products\/butenafine-hydrochloride.html\">Butenafine hydrochloride<\/a> analysis could clarify some issues, as many results in literature reveal opposite roles for the same signals, with the duration of specific pathways shaping the switch between one and another response. Although the functional enrichment analysis used here was helpful to identify possible relevant genes and pathways, a limitation of the present study is that we were only able to detect pathways whose genes are regulated by transcriptional activity. However, other relevant targets that are not regulated at the transcriptional level may have not been disclosed. These targets could be possibly regulated metabolically, dependent on phosphorylation status or other indirect effects of IPC or hemin treatment. In summary, the functional transcriptional analysis conducted in this work allowed the detection of new targets, biological processes and signaling pathways associated with IRI and renoprotective defenses. Further <a href=\"http:\/\/www.abmole.com\/products\/chlorhexidine-hydrochloride.html\">Chlorhexidine hydrochloride<\/a> dissections of the molecular mechanisms found here are demanding to gain potential insights into the pathophysiological changes occurring in renal IRI. Moreover, further studies evaluating the protection properties of IPC and Hemin treatment may be an important agenda for the discovery of effective treatments to ischemia-related kidney diseases. Interleukin-1 receptor-associated kinases are intracellular kinases that belong to a family containing death domains. The IRAKs play important roles in signal transduction mediated by Toll-like receptors and interleukin-1 receptors. TLRs are crucial in the innate immune response to microbial pathogens because of their ability to recognize pathogen-associated molecular patterns. IL-1R and its family members, including IL-18R and IL-33R, are cytokine receptors that initiate and control inflammatory and immune responses. Unregulated TLR or IL-1R activation may lead to pathological conditions ranging from chronic inflammation to the onset of autoimmune disease. Several attempts have been made to modulate TLR\/IL-1R responses, including direct blocking of receptor activation and inhibition of downstream signaling pathways. Upon stimulation, IL-1R and all TLRs, except TLR3 and certain TLR4 signals, recruit the Toll\/IL-1 receptor domain-containing adaptor molecule, myeloid differentiation factor 88, through a TIR-TIR homotypic interaction, leading to the activation of NF-kB. In the case of TLR2 and TLR4, another TIR adaptor protein, Mal, recruits MyD88 to the receptor complex. TLR3 can signal independently of MyD88 via the TRIF pathway, which induces the activation of interferon regulatory factors and the production of type I interferons. TLR4 can also signal through TRIF via a bridging <img src=\"http:\/\/www.abmole.com\/upload\/structure\/PF-04620110-chemical-structure.gif\" align=\"left\" width=\"229\" style=\"padding:10px;\"\/>adaptor protein called TRIF-related adaptor molecule, resulting in a delayed MyD88independent NF-kB response. Formation of the TLR receptor-adaptor complex leads to the recruitment of IRAKs. Upon recruitment, IRAK4 catalyzes the phosphorylation of key serine and threonine residues in IRAK1.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>We found relevant this time interval because unpublished data from our laboratory showed that the peak of Hmox-1 expression occurs around 6 hours after reperfusion, providing a reasonable evidence that this time point should be the best to compare changes between the groups shown in our manuscript. As we focused on the transcriptome analysis, we &hellip; <a href=\"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/2019\/06\/25\/phosphorylation-promotes-autophosphorylation-irak1-dissociates-receptor-complex\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;This phosphorylation promotes the autophosphorylation of IRAK1 which then dissociates from the receptor complex&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/1191"}],"collection":[{"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/comments?post=1191"}],"version-history":[{"count":1,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/1191\/revisions"}],"predecessor-version":[{"id":1192,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/1191\/revisions\/1192"}],"wp:attachment":[{"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/media?parent=1191"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/categories?post=1191"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/tags?post=1191"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}